Clinic
Memorial Hermann Health System
Memorial Hermann Health System was paid $8.53M by Medicaid between Feb 2020 and Dec 2024, across 82 billing codes. Its largest line is 99284, emergency room visit (serious) — 60% of everything it billed.
33Billing provider infoMEMORIAL HERMANN HEALTH SYSTEM
HOUSTON, TX 77024
HOUSTON, TX 77024
33aNPI1740233782assigned 05/19/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$8.53M
24GClaims71,924
24DCodes billed82
24AFirst – last monthFeb 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#51 of 320
Median peer was paid$205K
This provider vs. median42×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 299 | $56K | |
| 2021 | 14,210 | $1.43M | |
| 2022 | 20,769 | $2.27M | |
| 2023 | 24,224 | $3.49M | |
| 2024incomplete | 12,422 | $1.28M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 60% | 9,836 | 9,333 | $5.16M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 9,999 | 9,778 | $1.26M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.2% | 1,532 | 1,442 | $527K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 10,225 | 8,992 | $207K |
| 55180 | 2.4% | 53 | 50 | $202K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 4,270 | 4,171 | $187K |
| 80053 | Comprehensive metabolic panel | 2.1% | 4,742 | 4,177 | $178K |
| 87400 | 1.9% | 4,128 | 2,051 | $160K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 2,053 | 1,923 | $130K |
| 93975 | 1.5% | 590 | 533 | $126K | |
| 81001 | 1.2% | 5,040 | 4,795 | $103K | |
| 76801 | <1% | 462 | 410 | $47K |
70 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 284 | $32K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 476 | $26K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,255 | $21K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 861 | $19K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,126 | $18K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 198 | $18K |
| 84703 | <1% | 518 | $12K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 44 | $10K |
| 87807 | <1% | 306 | $10K | |
| 84702 | <1% | 646 | $9K | |
| 84484 | <1% | 1,167 | $7K | |
| 43235 | <1% | 15 | $7K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 505 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 159 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 81 | $3K |
| J3490 | Unclassified drugs | <1% | 212 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 262 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 92 | $3K |
| 83690 | <1% | 681 | $3K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 304 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 353 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 15 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 65 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 214 | $1K |
| 84450 | <1% | 156 | $1K | |
| 59025 | Fetal non-stress test | <1% | 16 | $1K |
| 84075 | <1% | 157 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 27 | $1K |
| 86901 | <1% | 630 | $1K | |
| 86900 | <1% | 631 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 29 | $837.17 |
| 85730 | <1% | 621 | $830.67 | |
| 82550 | <1% | 327 | $824.81 | |
| 82247 | <1% | 162 | $805.18 | |
| 86850 | <1% | 81 | $783.29 | |
| 85610 | <1% | 762 | $779.25 | |
| 87081 | <1% | 25 | $759.31 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $748.76 |
| 84155 | <1% | 157 | $625.57 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 72 | $535.64 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 87 | $432.02 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 59 | $385.43 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $364.92 |
| 82040 | <1% | 164 | $320.07 | |
| 96376 | <1% | 43 | $245.39 | |
| 83880 | <1% | 13 | $242.90 | |
| 80047 | <1% | 167 | $203.25 | |
| 80076 | <1% | 42 | $179.43 | |
| 82947 | <1% | 543 | $161.99 | |
| 83735 | <1% | 87 | $159.96 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 122 | $158.23 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 704 | $150.72 |
| 36000 | <1% | 12 | $141.18 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 691 | $127.17 |
| 83605 | <1% | 13 | $108.57 | |
| J2704 | Injection, propofol, 10 mg | <1% | 343 | $88.19 |
| 85014 | <1% | 250 | $83.26 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 286 | $58.93 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 60 | $45.02 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 24 | $44.66 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 14 | $32.64 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 60 | $31.45 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 18 | $30.96 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17 | $22.26 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 302 | $21.12 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 80 | $21.05 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14 | $14.30 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 21 | $3.67 |
| G0378 | Hospital observation service, per hour | 0% | 12 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGORDON, DEBORAH (EVP- CAO- CHIEF LEGAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Memorial Hermann Health System | Houston, TX | $137K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.